|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/553 | (2006.01) |
| A61P 35/04 | (2006.01) |
| (11) | Patento numeris | 3579840 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18704555.4 |
| Europos patento paraiškos padavimo data | 2018-02-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/053457 |
| Data | 2018-02-12 |
| (87) | Numeris | WO 2018/146313 |
| Data | 2018-08-16 |
| (30) | Numeris | Data | Šalis |
| PA201770091 | 2017-02-10 | DK |
| (72) |
FALTUM, Carsten , CH
JENSEN, Leif Helth , CH
DJAMGOZ, Mustafa , GB
|
| (73) |
Celex Oncology Innovations Limited ,
101 New Cavendish Street, London W1W 6XH,
GB
|
| (54) | TREATMENT OF CANCER AND INHIBITION OF METASTASIS |
| TREATMENT OF CANCER AND INHIBITION OF METASTASIS |